Dr. S retweeted
Cleft Lip-Palate CNV Analysis Uncovers New Clefting Genes. Researchers profiled copy number variants in more than 1,100 individuals, identifying duplications or deletions in known disease genes and in new clefting gene candidates. ow.ly/gbBr104ls9V
Dr. S retweeted
I go to the website
So I can log in to Citrix
So I can send a push to Duo
So I can open Duo to confirm
So I can log in the portal
So I can click on the app
So I can download the app
So I can open the app
So I can log in…
to EPIC ✨ – at Palo Alto, CA
Dr. S retweeted
In a randomized trial of patients with limb ischemia, those assigned to bypass surgery as compared with endovascular therapy as an initial strategy had fewer adverse limb events or all-cause death at a median of 2.7 years. #AHA22 nej.md/3U5wZ5w
Dr. S retweeted
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes #BetaBionics (single hormone setting)
nejm.org/doi/full/10.1056/NE…
Dr. S retweeted
Hair Repigmentation Induced by Nilotinib | NEJM
Nilotinib is reputedly a senolytic, so just possibly this is an anti-aging effect.
nejm.org/na101/home/literatu… nejm.org/doi/full/10.1056/NE…
Dr. S retweeted
I see that the xenotransplant researchers are putting some counter spin on the detection of a pig virus, pCMV, in the first gene-edited pig heart transplant.
Let's analyze:
Dr. S retweeted
Love how this Boston-area Luddite—who has never bothered to visit $DNA —is now unwittingly doing stealth marketing for $DNA
Tweets at 4:19pm after spending 10 mins reading PR (too lazy to compare to SPAC deck #’s)
By ~4:35pm, he finds out he is *IN* the new slides 😂
#synbio
Key figures picked out from $DNA 4Q21 results press release
• $34M in Foundry revenue in 4Q21
• $113M in Foundry revenue in FY21 (SPAC deck had $100M; consensus $108M)
• Guide of $165-$180M for Foundry revenue in FY22 (vs. $175M in SPAC deck)
#synbio
prnewswire.com/news-releases…
Dr. S retweeted
Pacira’s Lawsuit Against Anesthesiology Dismissed
‘This decision from the federal court makes clear that pharmaceutical companies are not free to intimidate the scientific process by filing lawsuits. This is a landmark win for science.” ‘
asahq.org/about-asa/newsroom…
Dr. S retweeted
A federal judge has dismissed an unusual libel lawsuit brought by Pacira BioSciences that claimed a medical journal published articles that were based on “faulty scientific research” that portrayed its only medicine as ineffective. buff.ly/3Gzvm8Q
Dr. S retweeted
I wonder how good many vaccines would be if we regularly hunted their corresponding viruses down in every corner of the country with PCR, detecting as many asymptomatic infections and/or breakthroughs as possible.
Dr. S retweeted
Extraordinary turn of events $PCRX investor.pacira.com/news-rel…




























